Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus

Screening for cognitive impairment (CI) in systemic lupus erythematosus (SLE) relies on the American College of Rheumatology (ACR) neuropsychological battery (NB). By studying the concurrent criterion validity, our goal was to assess the Montreal Cognitive Assessment (MoCA) as a screening tool for CI compared to the ACR‐NB and to evaluate the added value of the MoCA to the Automated Neuropsychological Assessment Metrics (ANAM).

[1]  D. Beaton,et al.  Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus , 2021, Lupus.

[2]  O. Tayer-Shifman,et al.  Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management , 2021, Drugs & Aging.

[3]  J. Stout,et al.  Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE , 2021, Lupus Science & Medicine.

[4]  E. Karademas,et al.  Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample , 2021, Lupus.

[5]  D. Beaton,et al.  Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review. , 2021, Seminars in arthritis and rheumatism.

[6]  Thomas V Perneger,et al.  How to use likelihood ratios to interpret evidence from randomized trials. , 2021, Journal of clinical epidemiology.

[7]  C. Baum,et al.  Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life , 2021, Lupus.

[8]  O. Tayer-Shifman,et al.  Assessment of Cognitive Function in Systemic Lupus Erythematosus , 2021, Outcome Measures and Metrics in Systemic Lupus Erythematosus.

[9]  Xuebiao Peng,et al.  Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus , 2020, Lupus.

[10]  D. Beaton,et al.  Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus , 2020, Arthritis care & research.

[11]  L. Chan,et al.  Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia , 2019, Lupus.

[12]  John Muschelli,et al.  ROC and AUC with a Binary Predictor: a Potentially Misleading Metric , 2019, Journal of Classification.

[13]  M. Luggen,et al.  Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly , 2018, Lupus.

[14]  S. Beyea,et al.  Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions , 2018, Arthritis & rheumatology.

[15]  S. Cumming,et al.  Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review , 2018, Arthritis care & research.

[16]  Kenneth Colosimo,et al.  Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus , 2017, The Journal of Rheumatology.

[17]  G. Valdivia,et al.  Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus , 2017, Scandinavian journal of rheumatology.

[18]  Saira Elaine Anwer Khan,et al.  Cognitive dysfunction in patients with Systemic Lupus Erythematosus , 2017, Pakistan journal of medical sciences.

[19]  G. Ferreira,et al.  Executive dysfunction, obsessive–compulsive symptoms, and attention deficit and hyperactivity disorder in Systemic Lupus Erythematosus: Evidence for basal ganglia dysfunction? , 2016, Journal of the Neurological Sciences.

[20]  Ralf Dresner,et al.  Health Measurement Scales A Practical Guide To Their Development And Use , 2016 .

[21]  L. Fratiglioni,et al.  Mild cognitive impairment: a concept in evolution , 2014, Journal of internal medicine.

[22]  D. Beebe,et al.  Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood‐onset systemic lupus erythematosus , 2013, Arthritis care & research.

[23]  J. Fisk,et al.  Screening for Cognitive Impairment in Systemic Lupus Erythematosus , 2012, The Journal of Rheumatology.

[24]  M. Blettner,et al.  Concordance analysis: part 16 of a series on evaluation of scientific publications. , 2011, Deutsches Arzteblatt international.

[25]  A. Piatti,et al.  Cognitive dysfunction in SLE: development of a screening tool , 2011, Lupus.

[26]  J. Ioannidis,et al.  EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs , 2010, Annals of the rheumatic diseases.

[27]  J. Fisk,et al.  Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests. , 2010, Arthritis and rheumatism.

[28]  F. Cendes,et al.  Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study. , 2009, Arthritis and rheumatism.

[29]  C. Filley,et al.  Cognitive dysfunction in systemic lupus erythematosus: past, present, and future. , 2008, Arthritis and rheumatism.

[30]  M. Petri,et al.  Cognitive function in a systemic lupus erythematosus inception cohort. , 2008, The Journal of rheumatology.

[31]  V. Mok,et al.  The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. , 2008, The Journal of rheumatology.

[32]  J. Mikdashi.  Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials , 2007, Lupus.

[33]  Steven McGee,et al.  Simplifying likelihood ratios , 2002, Journal of General Internal Medicine.

[34]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[35]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[36]  S. West,et al.  Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[37]  P. Zee,et al.  Factors Influencing Cognitive Function, Sleep, and Quality of Life in Individuals With Systemic Lupus Erythematosus: A Review of the Literature , 2004, The Clinical neuropsychologist.

[38]  J. Brandt,et al.  Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. , 1999, The Clinical neuropsychologist.

[39]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[40]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[41]  M. Liang,et al.  A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[42]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.